Currently the market prices PAA at $61m, and this for a company that doesn't return a profit so a lot of the so called current progress has been built into the market cap.
PAA has around has around 316m shares on issue, so let's say the dog cancer has already been built into current market cap so that leaves a So far unproven human cancer drug yet to pass a phase 2 trial and maybe a covid 19 drug but yet to pass any human trials.
So what is needed is for the human trials to commence asap and covid Human trials to prove positive.
If human cancer trial passes i see max sp of around $1.70 a share, if covid Human trial proven positive i think max sp between $6 to $8.
Should either human cancer trial or covid 19 fail then it will all depend on the Elanco deal
PHARMAUST ALL SET FOR ELY LILLY T/O, page-164
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.0¢ | $191.1K | 906.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1300 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 9563 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.000 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.0¢ | 22.5¢ | 20.5¢ | 533029 | ||
| Last updated 15.54pm 03/05/2024 ? | |||||
| PAA (ASX) Chart |